Almonair Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.65 M
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 M
- Revenue Growth -1.81%
- Profit Growth -51.65%
- Ebitda 9.99%
- Net Worth 6.45%
- Total Assets 23.05%
About Almonair Laboratories
Almonair Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 2014 and has a history of Ten years and ten months. Its registered office is in Udham Singh Nagar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.65 M.
The company currently has active open charges totaling ₹1.10 M.
Chandra Gangwar and Pravesh Gangwar serve as directors at the Company.
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24200UR2014PTC001122
- Company No.
001122
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Almonair Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Gangwar  | Director | 10-Apr-2014 | Current |
| Pravesh Gangwar | Director | 28-Jan-2016 | Current |
Financial Performance of Almonair Laboratories.
Almonair Laboratories Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.81% decrease. The company also saw a substantial fall in profitability, with a 51.65% decrease in profit. The company's net worth moved up by a moderate rise of 6.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Almonair Laboratories?
In 2019, Almonair Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.10 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2020 | Others | ₹0.17 M | Open |
| 16 Dec 2017 | Others | ₹0.94 M | Open |
How Many Employees Work at Almonair Laboratories?
Unlock and access historical data on people associated with Almonair Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Almonair Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Almonair Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
